Geninus

Geninus Assets per Share

The Total Assets per Share of Geninus (389030.KQ) as of Nov 16, 2026 is 1,180.65 KRW. In the previous year, Total Assets per Share was 992.82 KRW — a change of 18.92% (higher).

Assets per Share

1,180.65KRW

YoY

18.92%

Last updated:

Total Assets per Share of Geninus is 2025 1,180.65 KRW. Total Assets per Share of Geninus was 2024 992.82 KRW. It decreases by 18.92% higher compared to the previous year.

The Geninus Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
100.35 KRW
Jan 1, 2019
389.57 KRW
Jan 1, 2020
912.04 KRW
Jan 1, 2021
1,742.11 KRW
Jan 1, 2022
1,375.10 KRW
Jan 1, 2023
1,215.97 KRW
Jan 1, 2024
992.82 KRW
Jan 1, 2025
1,180.65 KRW
The Geninus Assets per Share history
YEARAssets per ShareYoY
1,180.65KRW+18.92%
992.82KRW-18.35%
1,215.97KRW-11.57%
1,375.10KRW-21.07%
1,742.11KRW+91.01%
912.04KRW+134.12%
389.57KRW+288.23%
100.35KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Geninus Stock analysis

What does Geninus do? Geninus Inc. generates revenue through the provision of single cell analysis services and genetic testing for disease prediction to the public. The company develops and manufactures genome analysis solutions, including cancer genome analysis based on tissue biopsy, and offers personal genetic testing services. Additionally, Geninus Inc. engages in software development and a rental business as part of its product portfolio. The primary customers are individuals seeking genetic insights for health management and healthcare providers requiring advanced genomic analysis tools. The company's products include NGS-based genome analysis technology, cancer genome analysis solutions, and personal genetic testing services. These offerings target healthcare institutions, medical professionals, and consumers interested in personalized health assessments. Geninus Inc. also develops software for genomic data processing, which supports its service delivery and rental business model. Revenue streams are derived from direct sales of genome analysis solutions, service fees for single cell and cancer genome analysis, and subscriptions for software and rental services. The firm's focus on NGS technology positions it within the biotechnology sector, serving both clinical and consumer markets with a range of genomic services and products. Geninus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Geninus stock

Total Assets per Share of Geninus is 1,180.65 KRW in 2025.

Total Assets per Share of Geninus changed from 992.82 KRW to 1,180.65 KRW, representing a 18.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Geninus since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Geninus

All Key Metrics — Geninus